Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 26.8B | 22.9B | 19.1B | 25.5B |
Cost of revenue | 20.9B | 18.5B | 14.2B | 19.6B |
Gross profit | 5.9B | 4.4B | 4.9B | 5.8B |
Operating expense | ||||
Research & development | 873.5M | 1.1B | 823.1M | 888.9M |
Selling general and admin | 2.5B | -664.5M | 3.3B | 817.4M |
Other operating expenses | 127.6M | 144.1M | 86.7M | 126.3M |
Operating income | 2.6B | 1.8B | 2.0B | 3.2B |
Non operating interest income | ||||
Income | 14.8M | 117.5M | 34.3M | 215.4M |
Expense | 328.3M | 437.2M | 146.7M | 408.9M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 862.9M | 1.6B | 2.2B |
Tax provision | 385.8M | 198.1M | 44.1M | 66.2M |
Net income | 2.0B | 664.8M | 1.6B | 2.1B |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 11.8B | — | — | — |
Diluted average shares | 11.8B | — | — | — |
EBITDA | 3.1B | 1.8B | 2.2B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -8.3M | 2.3M | 17.1M | -25.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |